Agency
Foundation Care LLC
Foundation Care LLC was paid $754K by Medicaid between Jan 2018 and Mar 2023, across 9 billing codes. Its largest line is J7639, Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram — 72% of everything it billed.
33Billing provider infoFOUNDATION CARE LLC
CHESTERFIELD, MO 63005
CHESTERFIELD, MO 63005
33aNPI1205831963assigned 06/17/2005
33bProvider typeHome Infusion Agency
28Total paid$754K
24GClaims3,277
24DCodes billed9
24AFirst – last monthJan 2018 – Mar 2023
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,424 | $325K | |
| 2019 | 710 | $205K | |
| 2020 | 642 | $114K | |
| 2021 | 320 | $57K | |
| 2022 | 156 | $40K | |
| 2023 | 25 | $13K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J7639 | Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 72% | 1,303 | 1,168 | $541K |
| Q0513 | Pharmacy dispensing fee for inhalation drug(s); per 30 days | 11% | 1,457 | 1,322 | $86K |
| J7682 | Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams | 9.4% | 217 | 191 | $71K |
| B4105 | In-line cartridge containing digestive enzyme(s) for enteral feeding, each | 3.3% | 15 | 12 | $25K |
| L8689 | External recharging system for battery (internal) for use with implantable neurostimulator, replacement only | 2.1% | 60 | 54 | $16K |
| L8681 | Patient programmer (external) for use with implantable programmable neurostimulator pulse generator, replacement only | 1.7% | 96 | 90 | $13K |
| A4253 | Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips | <1% | 31 | 30 | $2K |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 67 | 54 | $443.64 |
| A4259 | Lancets, per box of 100 | <1% | 31 | 30 | $311.58 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCICCOLELLA-KAHL, JESSICA (PRESIDENT, DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Acariahealth Pharmacy 12 INC | Hawthorne, NY | $11.13M |
| Acariahealth Pharmacy #14, INC. | Sacramento, CA | $1.07M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.